Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease

J Gastroenterol Hepatol. 2019 Jun;34(6):1093-1099. doi: 10.1111/jgh.14470. Epub 2018 Oct 4.

Abstract

Background and aims: Patients with cirrhosis and portal hypertension often develop complications relating to hepatic excretory dysfunction. The standard measurement of the hepatic excretion is the constant infusion indocyanine green clearance (ICGCI ) technique. The ICG 15-min retention test (ICG-r15) is faster, more patient friendly, and cheaper. The aims were to compare the ICG-r15 test with the standard method, to assess relations to patient characteristics and survival, and to assess the ICG-r15 level in healthy control subjects.

Methods: This study included 68 patients with cirrhosis and portal hypertension (Child class A/B/C:17/37/14). All patients underwent a full liver vein catheterization and hemodynamic evaluation with determination of ICG-r15 and ICGCI as the reference in a subset of 38 patients. Sixteen healthy control subjects were included for compiling a reference interval.

Results: The ICG-r15 was increased in the cirrhotic patients with increasing values in parallel with liver dysfunction (15/41/58%) in Child class A/B/C compared with 7% in the controls (P < 0.001). ICG-r15 correlated highly significantly with the ICGCI (r = -0.96, P < 0.0001) and in a multivariate regression analysis with hepatic venous pressure gradient, markers of liver dysfunction and hyperdynamic circulation (P < 0.05-0.005). In the control group, normal reference values ranged from 0% to 13%. In addition, ICG-r15 was significantly related to mortality in the patient group (P = 0.02).

Conclusions: Indocyanine green-r15 reflects portal hypertension, the degree of hepatic failure, and survival and may replace the standard ICGCI . A more elaborated reference interval needs to be compiled, and the prognostic value of ICG-r15 should be validated.

Keywords: excretory dysfunction; indocyanine green clearance; liver failure.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Hypertension, Portal / complications
  • Hypertension, Portal / diagnosis*
  • Hypertension, Portal / mortality
  • Indocyanine Green*
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / diagnosis*
  • Liver Cirrhosis / mortality
  • Liver Failure / diagnosis
  • Liver Function Tests / methods*
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Survival Rate

Substances

  • Indocyanine Green

Grants and funding